empty
 
 
pl
Wyszukaj
Obsługa klienta
Szybkie założenie konta
Platforma handlowa
Wpłata/Wypłata
Wyszukaj
Dla Początkujących Dla Traderów Dla Partnerów Zrób sobie przerwę Informacje o InstaSpot
pl
#A Return to the list of instruments #ACB

Currency converter

AbbVie Inc
249.71 USD
09 Sep 2026 21:59
Price Change (% chg)
$-0.05
(-0.02%)
Prev Close
Prev Close

Closing price, the previous day.
$249.56
Open
Open

Opening price.
$256.24
Day's High
Day's High

The highest price over the last trading day.
$250.79
Day's Low
Day's Low

The lowest price over the last trading day
$247.36
Week High
Week High

Price range high in the last week
$262.01
Week Low
Week Low

Price range low in the last week
$247.36
Download archive
Buy
249.92
Sell
249.71
Open the chart in full screen view
Buy
249.92
Sell
249.71
Download archive
Open the chart in full screen view

AbbVie Inc. About company

AbbVie Inc. is an American biopharmaceutical company. It was founded in 2013 after Abbott Laboratories split into two separate companies. In the same year, AbbVie Inc. was listed on the New York Stock Exchange as a separate company under the ABBV ticker.

The company’s mission is to develop and deliver innovative medicines that solve serious health issues. Since its foundation, the company has invested more than $50 billion in the research and development of world-class medicines.

Nowadays, it employs more than 50,000 people worldwide. Its production facilities and research centers are located in 20 countries.

In 2021, the company's total revenue amounted to $56.2 billion. AbbVie's GAAP net profit for the 6 months of 2022 totaled $5.42 billion, an increase of 25.4% compared to $4.32 billion in the previous year. Its revenue jumped by 4.3% to $28.12 billion against $26.97 billion a year earlier.

AbbVie Inc. shares and factors impacting their price

Currently, the company's shares are traded between $140-145, which is four times higher since its IPO 10 years ago. Over the past year, the stock price has fluctuated in the range of $106.86 -$175.91.

Its shares are growing slowly but surely without sharp price swings. Thus, the purchase of AbbVie Inc. stock can be deemed a good long-term investment.

AbbVie allocates 45-50% of available funds annually to pay dividends to its shareholders. The amount of dividends is quite decent. For this reason, the company is classified as a dividend aristocrat.

Nie możesz teraz rozmawiać przez telefon?
Zadaj pytanie na czacie.